Cargando…

Downregulation of circLPAR3 inhibits tumor progression and glycolysis by liberating miR‐144‐3p and upregulating LPCAT1 in oral squamous cell carcinoma

BACKGROUND: Increasing evidence demonstrated the important roles of circular RNAs (circRNAs) in human cancer progression, including oral squamous cell carcinoma (OSCC). The study intentions were to explore the role and molecular mechanism of hsa_circ_0004390 (circLPAR3) in OSCC progression. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Zhijian, Pan, Chao, Xie, Honghui, Ning, Yanyang, Li, Shuangjiang, Xiao, Haibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008151/
https://www.ncbi.nlm.nih.gov/pubmed/35434335
http://dx.doi.org/10.1002/lio2.771
_version_ 1784686985214951424
author Su, Zhijian
Pan, Chao
Xie, Honghui
Ning, Yanyang
Li, Shuangjiang
Xiao, Haibo
author_facet Su, Zhijian
Pan, Chao
Xie, Honghui
Ning, Yanyang
Li, Shuangjiang
Xiao, Haibo
author_sort Su, Zhijian
collection PubMed
description BACKGROUND: Increasing evidence demonstrated the important roles of circular RNAs (circRNAs) in human cancer progression, including oral squamous cell carcinoma (OSCC). The study intentions were to explore the role and molecular mechanism of hsa_circ_0004390 (circLPAR3) in OSCC progression. METHODS: Expression of circLPAR3 in collected samples and cultured cell lines was detected with real‐time quantitative reverse transcription‐polymerase chain reaction (RT‐qPCR). Loss‐of‐function experiments were performed to determine the effect of circLPAR3 silencing on OSCC cell proliferation, migration, invasion, apoptosis, angiopoiesis, and glycolysis. The sponge function of circLPAR3 was predicted by bioinformatics analysis and validated by the dual‐luciferase reporter and RNA pull‐down assays. In vivo experiments were conducted to validate the function of circLPAR3. RESULTS: A marked increase in circLPAR3 expression was observed in OSCC samples and cell lines. Furthermore, circLPAR3 could distinguish OSCC samples from paired non‐tumor samples, and patients with high circLPAR3 expression had a poor prognosis. Furthermore, circLPAR3 inhibition decreased OSCC growth in xenograft mouse models. Moreover, circLPAR3 silencing repressed cell proliferation, migration, invasion, angiopoiesis, glycolysis, and induced cell apoptosis in OSCC cells in vitro. Mechanically, circLPAR3 sponged miR‐144‐3p to prohibit the inhibiting effect of miR‐144‐3p on LPCAT1, thus promoting OSCC progression. CONCLUSION: CircLPAR3 exerted a tumor‐promoting effect on OSCC growth through elevating LPCAT1 expression via functioning as a miR‐144‐3p sponge. This study supports the possible role of circLPAR3 in the diagnosis, prognosis, and treatment of OSCC.
format Online
Article
Text
id pubmed-9008151
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-90081512022-04-15 Downregulation of circLPAR3 inhibits tumor progression and glycolysis by liberating miR‐144‐3p and upregulating LPCAT1 in oral squamous cell carcinoma Su, Zhijian Pan, Chao Xie, Honghui Ning, Yanyang Li, Shuangjiang Xiao, Haibo Laryngoscope Investig Otolaryngol Head and Neck, and Tumor Biology BACKGROUND: Increasing evidence demonstrated the important roles of circular RNAs (circRNAs) in human cancer progression, including oral squamous cell carcinoma (OSCC). The study intentions were to explore the role and molecular mechanism of hsa_circ_0004390 (circLPAR3) in OSCC progression. METHODS: Expression of circLPAR3 in collected samples and cultured cell lines was detected with real‐time quantitative reverse transcription‐polymerase chain reaction (RT‐qPCR). Loss‐of‐function experiments were performed to determine the effect of circLPAR3 silencing on OSCC cell proliferation, migration, invasion, apoptosis, angiopoiesis, and glycolysis. The sponge function of circLPAR3 was predicted by bioinformatics analysis and validated by the dual‐luciferase reporter and RNA pull‐down assays. In vivo experiments were conducted to validate the function of circLPAR3. RESULTS: A marked increase in circLPAR3 expression was observed in OSCC samples and cell lines. Furthermore, circLPAR3 could distinguish OSCC samples from paired non‐tumor samples, and patients with high circLPAR3 expression had a poor prognosis. Furthermore, circLPAR3 inhibition decreased OSCC growth in xenograft mouse models. Moreover, circLPAR3 silencing repressed cell proliferation, migration, invasion, angiopoiesis, glycolysis, and induced cell apoptosis in OSCC cells in vitro. Mechanically, circLPAR3 sponged miR‐144‐3p to prohibit the inhibiting effect of miR‐144‐3p on LPCAT1, thus promoting OSCC progression. CONCLUSION: CircLPAR3 exerted a tumor‐promoting effect on OSCC growth through elevating LPCAT1 expression via functioning as a miR‐144‐3p sponge. This study supports the possible role of circLPAR3 in the diagnosis, prognosis, and treatment of OSCC. John Wiley & Sons, Inc. 2022-03-11 /pmc/articles/PMC9008151/ /pubmed/35434335 http://dx.doi.org/10.1002/lio2.771 Text en © 2022 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Head and Neck, and Tumor Biology
Su, Zhijian
Pan, Chao
Xie, Honghui
Ning, Yanyang
Li, Shuangjiang
Xiao, Haibo
Downregulation of circLPAR3 inhibits tumor progression and glycolysis by liberating miR‐144‐3p and upregulating LPCAT1 in oral squamous cell carcinoma
title Downregulation of circLPAR3 inhibits tumor progression and glycolysis by liberating miR‐144‐3p and upregulating LPCAT1 in oral squamous cell carcinoma
title_full Downregulation of circLPAR3 inhibits tumor progression and glycolysis by liberating miR‐144‐3p and upregulating LPCAT1 in oral squamous cell carcinoma
title_fullStr Downregulation of circLPAR3 inhibits tumor progression and glycolysis by liberating miR‐144‐3p and upregulating LPCAT1 in oral squamous cell carcinoma
title_full_unstemmed Downregulation of circLPAR3 inhibits tumor progression and glycolysis by liberating miR‐144‐3p and upregulating LPCAT1 in oral squamous cell carcinoma
title_short Downregulation of circLPAR3 inhibits tumor progression and glycolysis by liberating miR‐144‐3p and upregulating LPCAT1 in oral squamous cell carcinoma
title_sort downregulation of circlpar3 inhibits tumor progression and glycolysis by liberating mir‐144‐3p and upregulating lpcat1 in oral squamous cell carcinoma
topic Head and Neck, and Tumor Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008151/
https://www.ncbi.nlm.nih.gov/pubmed/35434335
http://dx.doi.org/10.1002/lio2.771
work_keys_str_mv AT suzhijian downregulationofcirclpar3inhibitstumorprogressionandglycolysisbyliberatingmir1443pandupregulatinglpcat1inoralsquamouscellcarcinoma
AT panchao downregulationofcirclpar3inhibitstumorprogressionandglycolysisbyliberatingmir1443pandupregulatinglpcat1inoralsquamouscellcarcinoma
AT xiehonghui downregulationofcirclpar3inhibitstumorprogressionandglycolysisbyliberatingmir1443pandupregulatinglpcat1inoralsquamouscellcarcinoma
AT ningyanyang downregulationofcirclpar3inhibitstumorprogressionandglycolysisbyliberatingmir1443pandupregulatinglpcat1inoralsquamouscellcarcinoma
AT lishuangjiang downregulationofcirclpar3inhibitstumorprogressionandglycolysisbyliberatingmir1443pandupregulatinglpcat1inoralsquamouscellcarcinoma
AT xiaohaibo downregulationofcirclpar3inhibitstumorprogressionandglycolysisbyliberatingmir1443pandupregulatinglpcat1inoralsquamouscellcarcinoma